GenMark Diagnostics Inc (NASDAQ:GNMK)

6.23
Delayed Data
As of 11:30am ET
 -0.22 / -3.41%
Today’s Change
3.63
Today|||52-Week Range
13.67
+49.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues30.6M39.4M49.3M52.5M
 
 
 
 
 
Cost of Goods Sold10.5M11.9M15.8M25.8M
 
 
 
 
 
Depreciation And Amortization2.7M3.4M3.9M5.3M
 
 
 
 
 
 
Operating ExpensesGross Income17.5M24.1M29.6M21.4M
 
 
 
 
 
General Expenses56.5M65.6M78.6M79.5M
 
 
 
 
 
Other Operating Expenses0.000.000.001.4M
 
 
Research And Development31.8M37.5M49.5M42.8M
 
 
 
 
 
Total Operating Expenses69.6M80.9M98.3M112.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.1M-41.5M-49.0M-59.5M
 
 
 
 
 
Interest Expense On Debt20.0K880.0K1.5M3.0M
 
 
 
 
 
Other Expenses-6.0K133.0K-160.0K249.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.8M-42.2M-50.5M-61.7M
 
 
 
 
 
Income Taxes-573.0K-40.0K-100.0K-101.0K
 
 
 
 
 
Net Income-38.3M-42.2M-50.6M-61.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.3M42.2M44.1M51.2M
 
 
 
 
 
Shares To Calculate EPS Diluted41.3M42.2M44.1M51.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.93-$1.00-$1.15-$1.21
 
 
 
 
 
EPS Diluted-$0.93-$1.00-$1.15-$1.21